# CDT Equity Inc. (CDTTW) — capital_raise/atm_program [pending]
Source: SEC API (secapi.ai) · situation sit_9e4fb66e9a73f6245eb9 · retrieved 2026-08-12T07:21:44.821Z

## Overview
CDT Equity Inc. (formerly Conduit Pharmaceuticals) is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.

CDT Equity Inc. amended its senior secured convertible note with J.J. Astor & Co. on July 31, 2026, increasing the principal amount to $2,266,650 from $1,971,000 and adding a $377,775 restructuring premium. The note carries a 19% annual interest rate and is payable in 23 equal weekly installments of $104,187.65 commencing August 19, 2026 through January 20, 2027. On August 3, 2026, the parties entered into a third amendment, whereby the Lender advanced an additional $200,000 (net $181,850 after fees), increasing the total principal balance to $2,536,650. The Lender received warrants to purchase 37,500 shares at $7.20 per share. The note is convertible at the greater of 70% of the 20-day volume-weighted average price or the Floor Price (20% of the 20-day VWAP, adjusted every six months), subject to stockholder approval for issuances exceeding 19.99% of outstanding shares.

## Terms
- Counterparty: J.J. Astor & Co. · Deal value: $2.5M · Consideration: mixed · Price/share: $7.2

## Key dates
- Announced 2026-08-06 · Vote 2026-08-28 · Expiry 2027-02-10

## Timeline
- 2026-08-06 · 8-K (0001493152-26-036361): 8-K - CDT Equity Inc. — *CDT Equity Inc. (formerly Conduit Pharmaceuticals) is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.* CDT Equity Inc. amended its senior secured convertible note with J.J. Astor & Co. on July 31, 2026, increasing the principal amount to $2,266,650 from $1,971,000 and adding a $377,775 restructuring premium. The note carries a 19% annual interest rate and is payable in 23 equal weekly installments of $104,187.65 commencing August 19, 2026 through January 20, 2027. On August 3, 2026, the parties entered into a third amendment, whereby the Lender advanced an additional $200,000 (net $181,850 after fees), increasing the total principal balance to $2,536,650. The Lender received warrants to purchase 37,500 shares at $7.20 per share. The note is convertible at the greater of 70% of the 20-day volume-weighted average price or the Floor Price (20% of the 20-day VWAP, adjusted every six months), subject to stockholder approval for issuances exceeding 19.99% of outstanding shares.
  https://www.sec.gov/Archives/edgar/data/1896212/0001493152-26-036361.txt

## Citations
- 0001493152-26-036361 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226036361